"Bharat Biotech" News and Videos   LIVE

ℹ️ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets
New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human..
Credit: Mid-Day - Published 2 days ago

Credit: IndiaTimes - Published 2 days ago

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),..
Credit: IndiaTimes - Published 3 days ago

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous inactivated vaccine was developed and manufactured in Bharat..
Credit: DNA - Published 3 days ago

Indigenous vaccine trials start in July
Credit: Hindu - Published 3 days ago

CEPI, Ind-CEPI to fund a consortium comprising Bharat Biotech, International Vaccine Institute
Credit: Hindu - Published on June 3, 2020

The Covid-19 vaccine development is moving in a positive direction, next one month is very crucial, said Dr. Krishna Mohan Ella, Chief Executive Officer of..
Credit: Mid-Day - Published on June 2, 2020

Aims to launch human trials in India in December
Credit: Hindu - Published on May 20, 2020

Virus strain from NIV Pune transferred.
Credit: Hindu - Published on May 9, 2020

The Indian Council of Medical Research has partnered with Bharat Biotech International Limited to develop a fully indigenous vaccine for Covid-19, the apex..
Credit: IndiaTimes - Published on May 9, 2020

The Indian Council of Medical Research has partnered with Bharat Biotech International Limited to develop a fully indigenous vaccine for Covid-19, the apex..
Credit: IndiaTimes - Published on May 9, 2020

The team will use the virus strain isolated at ICMR’s National Institute of Virology (NIV), Pune. The strain has been successfully transferred from NIV to..
Credit: Zee News - Published on May 9, 2020

COVID-19 therapy plan gets nod from CSIR
Credit: Hindu - Published on May 8, 2020

Credit: IndiaTimes - Published on May 8, 2020

Six Indian companies are working on a vaccine for COVID-19, joining global efforts to find a quick preventive for the deadly infection spreading rapidly across..
Credit: Mid-Day - Published on April 16, 2020

The vaccine, likely to be named CoroFlu, will be built on a flu vaccine backbone named M2SR, which has already proved to be safe and well tolerant when given to..
Credit: Zee News - Published on April 4, 2020

The vaccine, likely to be named CoroFlu, will be built on a flu vaccine backbone named M2SR, which has already proved to be safe and well tolerant when given to..
Credit: Zee News - Published on April 4, 2020

Firm to develop and test one-drop, intranasal vaccine called ‘CoroFlu’
Credit: Hindu - Published on April 3, 2020

CoroFlu is a one drop COVID-19 nasal vaccine built on a flu vaccine “backbone” that has been shown to be safe and well-tolerated in humans, in Phase I and..
Credit: Hindu - Published on April 3, 2020

Phase-III clinical trial carried out in Nepal in over 10,000 children.
Credit: Hindu - Published on December 6, 2019

Credit: Indian Express - Published on November 13, 2019

Vaccine research and development organisation Hilleman Laboratories has entered into a collaboration with Bharat Biotech International Ltd (BBIL) for
Credit: Hindu - Published on June 26, 2019